Skip to main content
Account

Table 6 Dendrimer based anti-GBM drug delivery system

From: Nanoscale Drug Delivery Systems in Glioblastoma

Drug

Composite

Modification

Detail

Result

Celecoxib (CXB) [169]

CXB@G3BC31

Biotinylated third generation of the poly (amidoamine) dendrimer was substituted with 31 CXB residues

The cellular uptake, proliferation, migration and apoptosis were assessed in U-118 cells

Model organism nematode Caenorhabditis elegans was used in toxicological studies

Cellular accumulation of dendrimer NPs in the lysosomes of tumor cells

Up-regulated COX-2 level and cell cycle arrest

Anti-tumor effect in vitro

Arsenic trioxide (ATO) [170]

ATO@cRGD@mPEG@PAMAM

cRGD can bind to αvβ3 integrin peptides and combine with the integrin receptors on BBB

Cellular uptake, hemolytic toxicity and cytotoxicity were detected in C6 cells

Intracellular disposition and BBB penetration were assessed

Therapeutic efficacy was evaluated in Wistar rats model

Enhanced BBB penetration and intracellular disposition

Cell cycle perturbations in G2/M phase

Excellent therapeutic effect in vitro/vivo

TRAIL [171]

TRAIL@Tf@PAMAM

Transferrin (Tf) receptor were overexpressed on BBB and utilized for facilitating brain targeting

Cellular uptake and apoptosis were determined in C6 cells

Tumor xenografted SD rat model was established

MRI imaging was utilized to monitor therapeutic effect

Accumulated NPs in brain tumor site

Induced cell apoptosis

Prolonged mean survival time and decreased tumor volume

Rapamycin (RAPA) [172]

RAPA@ PAMAMOH

Hydroxyl PAMAM dendrimers (PAMAMOH) had the unique ability to target activated microglia

BV2 microglia were activated with IFNγ for inflammation analysis

Anti-proliferative activity in GL261 cells was detected by MTT assay

Systemic toxicity and anti-tumor evaluation were completed in C57BL/6 orthotopic mice model

Ablation and repolarization of TAMs

Augmented anti-proliferative and tumor specificity properties in vitro

Improved therapeutic efficacy in vivo

Doxorubicin [173]

DOX@Borneol@ANG-2@PAMAM

Angiopep-2 could specifically target LPR on BBB surface

Borneol promoted the permeation of drugs across BBB and enhanced their distribution in the brain tissue

Cellular uptake and intracellular disposition were detected through LSCM in HBMEC cells

BBB penetration model was established

In vitro cytotoxicity on HBMEC and C6 cells were evaluated

Sustained pH-sensitive DOX release

Enhanced cytotoxicity and BBB penetration

Promoted tumor specific NPs uptake level

Navigation